In the SpaceX Falcon 9 rocket, the research developed by the Research Center for Technologies for Society (C+) of the Universidad del Desarrollo will be tested in space, considered an extreme environment, and will thus see the possibility of creating medicines quickly and within everyone’s reach. both in space and on Earth.
A few days ago, the launch of the CRS-27 mission on the SpaceX Falcon 9 rocket to the international space station . Inside he understood the project AmpliRx Space Pharmacy an experimental platform for pharmaceutical manufacturing, which will be waiting to be used by personnel aboard the station in the coming months.
The initiative was developed by MakerHealth, a spin-off from Massachusetts Institute of Technology (MIT) founded by researcher José Gómez-Márquez, who also works with the Center for Research in Technologies for Society (C+) of the Faculty of Engineering of Development University in various projects.
On this occasion, the mission sent around sixty inaugural experiments which will enable the work carried out in the manufacture of biomaterials and drugs to be continued. The objective that the experiment can be tested in space, considered as an extreme environment, and thus glimpse the possibility of creating drugs quickly and within everyone’s reach both in space and on Earth.
Gómez Márquez emphasizes that “we learn to redesign sustainable, low-carbon manufacturing pathways to explore how sustainable drug production learn from the extreme environments of space and benefit from pharmaceutical access on Earth. By transforming the test tube and fluid chemistry set into a biochemical Lego set that can be mixed, shared and replicated, we are building a constellation of drug factories within everyone’s reach.”
Regarding the collaboration carried out by the UDD Engineering Research Center in this project, from C+ they explain that it was the technical assistance for the design of the objects themselves modifying aspects to optimize the performance of the device and, also, to adjust the parameters for distributed manufacturing in three different laboratories in a synchronized way, which allowed the production of more than 1,500 units which are now part of the experiment in orbit.
Food of the Year according to the New York Times: a Chilean study indicates that it reduces weight and protects against diabetes
“The establishment of international relations for the execution of research and development projects constitutes a fundamental pillar in this same environment, since it allows us to learn from each other on the resolution of various problems and, at the same time, to contribute globally to human development, which shows that in Chile you can collaborate and do world-class science,” said Martín Gaete, a C+ researcher who has collaborated directly with AmpliRx.
Note that this mission would be the first step to put AmpliRx in the hands of patients, clinicians and researchers in outer space and back on Earth.
Source: Latercera
I am David Jack and I have been working in the news industry for over 10 years. As an experienced journalist, I specialize in covering sports news with a focus on golf. My articles have been published by some of the most respected publications in the world including The New York Times and Sports Illustrated.
